• 1
    Xu ZH, Zhou HH. Cytochrome P450 1A2 in drug metabolism. J Clin Pharmacol 1996; 12: 115121.
  • 2
    Han XM, Zhou HH. Polymorphism of CYP450 and cancer susceptibility. Acta Pharmacol Sin 2000; 21: 673679.
  • 3
    Ouyang DS, Huang SL, Wang W, Xie HG, Xu ZH, Zhou HH. Phenotypic polymorphism and gender-related differences of CYP1A2 activity in a Chinese population. Br J Clin Pharmacol 2000; 49: 145151.
  • 4
    Nakajima M, Yokoi T, Mizutani M, Kinoshita M, Funayama M, Kamataki T. Genetic polymorphism in the 5′-flanking region of human CYP1A2 gene: Effect on the CYP1A2 inducibility in humans. J Biochem (Tokyo) 1999; 125: 803808.
  • 5
    Sachse C, Brockmoller J, Bauer S, Roots I. Functional significance of a C¡úA polymorphism in intron 1 of the cytochrome P450 CYP1A2 gene tested with caffeine. Br J Clin Pharmacol 1999; 47: 445449.
  • 6
    Chida M, Yokoi T, Fukui T, Kinoshita M, Yokota J, Kamataki T. Detection of three genetic polymorphisms in the 5′-flanking region and intron 1 of human CYP1A2 in the Japanese population. Jpn J Cancer Res 1999; 90: 899902.
  • 7
    Han XM, Chen XP, Wu QN, Jiang CH, Zhou HH. G-2964A and C734A genetic polymorphisms of CYP1A2 in Chinese population. Acta Pharmacol Sin 2000; 21: 10311034.
  • 8
    Han XM, OuYang DS, Lu PX, et al. Plasma caffeine metabolite ratio (17X/137X) in vivo associated with G-2964A and C734A polymorphisms of human CYP1A2. Pharmacogenetics 2001; in press.
  • 9
    Shu Y, Zhou HH. Individual and ethnic differences in CYP2C19 activity in Chinese populations. Acta Pharmacol Sin 2000; 21: 193199.
  • 10
    Andersson T, Regardh CG, Dahl-Puustinen ML, Bertilsson L. Slow omeprazole metabolizers are also poor S-mephentoin hydroxylators. Ther Drug Monit 1990; 12: 415416.
  • 11
    Rost KL, Brosicke H, Heinemeyer G, Roots I. Specific and dose-dependent enzyme induction in human beings. Hepatology 1994; 20: 12041212.
  • 12
    Rost KL, Roots I. Accelerated caffeine metabolism after omeprazole treatment is indicated by urinary metabolite ratios: Coincidence with plasma clearance and breath test. Clin Pharmacol Ther 1994; 55: 402411.
  • 13
    Parkinson A, Hurwitz A. Omeprazole and the induction of human cytochrome P-450: a response to concerns about potential adverse effects. Gastroenterology 1991; 100: 11571164.
  • 14
    Sarich T, Kalhorn T, Magee S, et al. The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoin. Clin Pharmacol Ther 1997; 62: 2128.